亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯系方式|購物車
企業會員第1年

鄭州鼎馳科技有限公司銷售二部  

醫藥原料 保健品原料 獸藥原料 維生素 植物提取物

搜索
新聞中心
  • 暫無新聞
產品分類
  • 暫無分類
聯系方式
  • 聯系人:張獻華
  • 電話:0371-53757073
  • 郵件:zzdingchi@163.com
  • 傳真:0371-60316268
  • QQ:2678580715
站內搜索
 
榮譽資質
  • 暫未上傳
友情鏈接
  • 暫無鏈接
首頁 > 供應產品 > 西力士/他達那非 鄭州供應
西力士/他達那非 鄭州供應
單價 2600.00 / 千克對比
銷量 暫無
發貨 河南鄭州市付款后3天內
庫存 1000千克起訂1千克
品牌 鼎馳
型號 171596-29-5
規格 醫藥級
過期 長期有效
更新 2013-07-20 11:47
 
詳細信息

CAS: 171596-29-5

化學名: (6R-12aR)-2,3,6,7,12,12a-六氫化-2-甲基-6-(3,4-(亞甲二氧基)-苯基)-吡嗪并[1,2:1,6]

分子式:C22H19N3O4

用法用量:本品可制成片劑、飲劑、膠囊等主要產品,成人每日每次10—30mg用量.

CAS: 171596-29-5

化學名: (6R-12aR)-2,3,6,7,12,12a-六氫化-2-甲基-6-(3,4-(亞甲二氧基)-苯基)-吡嗪并[1,2:1,6]

分子式:C22H19N3O4

用法用量:本品可制成片劑、飲劑、膠囊等主要產品,成人每日每次10—30mg用量.


©2025 鄭州鼎馳科技有限公司銷售二部 版權所有   技術支持:化工網   訪問量:8268  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |